Showing results (1241-1250 of 1,373) with videos related to
Sort By:
Pageof 138
Leukemia|August 10, 2012
Minor clone provides a reservoir for relapse in multiple myelomaF Magrangeas, H Avet-Loiseau, W Gouraud, et al.Genomics, Proteomics & Bioinformatics|April 13, 2025
PlateletBase: A Comprehensive Knowledgebase for Platelet Research and Disease InsightsHuaichao Luo, Changchun Wu, Sisi Yu, et al.Health Science Reports|January 31, 2019
Bortezomib retreatment for relapsed and refractory multiple myeloma in real-world clinical practiceCyrille Hulin, Javier de la Rubia, Meletios A Dimopoulos, et al.British Journal of Haematology|November 20, 2020
Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open-label Phase II studyAjai Chari, Paula Rodriguez-Otero, Helen McCarthy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2010
Bortezomib plus dexamethasone induction improves outcome of patients with t(4;14) myeloma but not outcome of patients with del(17p)Hervé Avet-Loiseau, Xavier Leleu, Murielle Roussel, et al.International Journal of Environmental Research and Public Health|June 2, 2021
Maternal Ambient Exposure to Atmospheric Pollutants during Pregnancy and Offspring Term Birth Weight in the Nationwide ELFE CohortMarion Ouidir, Emie Seyve, Emmanuel Rivière, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2017
Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-AnalysisPhilip L McCarthy, Sarah A Holstein, Maria Teresa Petrucci, et al.Science Robotics|April 20, 2022
Exploring planet geology through force-feedback telemanipulation from orbitMichael Panzirsch, Aaron Pereira, Harsimran Singh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2014
Front-line transplantation program with lenalidomide, bortezomib, and dexamethasone combination as induction and consolidation followed by lenalidomide maintenance in patients with multiple myeloma: a phase II study by the Intergroupe Francophone du MyélomeMurielle Roussel, Valérie Lauwers-Cances, Nelly Robillard, et al.European Journal of Haematology|July 21, 2018
Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practiceEvangelos Terpos, Eirini Katodritou, Javier de la Rubia, et al.Pageof 138